僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Abelacimab （MAA868） is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies